Healthway Medical (5NG.SG) +9.7% at 2-month high of $0.17 on robust volume. Traders attribute the gains to expectations the company may unveil new major shareholders after Reuters reported a senior executive saying Healthway is speaking to unnamed potential investors. 

The stock is one of the top small-cap performers in Singapore in 1H10, rising to a 52-week high of S$0.21 in June, as Singapore billionaire Peter Lim became a substantial shareholder by buying from the open market. 

 

But the price has since pulled back with Lim, who’s in the midst of acquiring Thomson Medical Centre (5FV.SG), ceasing to be a substantial shareholder in October after cutting his stake to 4.85% from 7.17%. “With the spike up today, the stock is challenging the downward trend line resistance formed since the correction from July,” says Kim Eng Securities; tips initial resistance at $0.18, then $0.195.